News in the Life Sciences Industry

SINGAPORE, April 15, 2019 /PRNewswire/ -- Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies targeting solid tumors, today announced that it has entered into an agreement with Merck (known as MSD outside the US and... Read more ››

TAIPEI, Taiwan and TOKYO, March 5, 2019 /PRNewswire/ -- Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate communication between diabetics and healthcare providers. Last December, the two companies agreed to support the localization... Read more ››